This is a non-core endpoint: only basic statistics are computed.
Soft tissue disorders in diseases classified elsewhere
M13_SOFTTISSUEINOTH
musculoskeletal system disease: A disease involving the musculoskeletal system. [database_cross_reference: MONDO:DesignPattern]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
27 |
4. Check minimum number of eventsNone |
27 |
5. Include endpointsNone |
27 |
6. Filter based on genotype QC (FinnGen only) |
27 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Soft tissue disorders in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Soft tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 239 | 122 | 116 |
| Only index persons | 226 | 117 | 109 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 49.88 | 49.37 | 50.50 |
| Only index persons | 49.69 | 49.02 | 50.42 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 27 | 17 | 10 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 52.54 | 52.57 | 52.48 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
19
65
7.43
5.66
8.4
3.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
13
43
4.90
3.88
9.8
2.7
—
—
—
0
0
(3015736) pH of Urine
17
72
4.67
3.67
8.4
2.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
9
8.17
3.04
3.3
6.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
7
16
5.50
2.68
4.3
12.5
g/l
119.4
116.4
—
7
16
(3041096) Erythrocytes [Presence] in Urine by Automated
12
48
3.70
2.62
3.2
3.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
18
4.86
2.44
1.4
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
9
30
3.97
2.43
3.2
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
25
4.10
2.32
1.3
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
13
63
3.05
2.01
5.8
2.8
u/l
26.8
30.9
0.60
13
57
(4010399)
6
17
4.22
1.96
2.5
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
12
4.84
1.91
5.4
9.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
24
3.56
1.87
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
24
3.56
1.87
12.6
5.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9
37
3.13
1.68
5.1
4.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
28
3.01
1.58
1.7
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
17
3.36
1.42
3.0
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
21
150
2.79
1.40
4.8
3.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
20
140
2.65
1.38
8.3
3.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
38
2.56
1.32
1.3
1.6
—
—
—
0
0
(4035726)
0
33
0.00
1.26
0.0
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
34
2.42
1.13
1.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5
22
2.55
1.08
1.2
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
11
65
2.17
1.01
4.5
2.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
6
29
2.37
0.96
1.8
2.3
g/l
2.4
2.3
—
6
29
(42870588) Differential panel, method unspecified - Blood
11
69
2.00
0.85
7.1
3.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
10
61
2.02
0.83
3.6
3.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
19
146
2.01
0.81
7.1
3.6
mm/h
14.1
13.5
0.08
19
127
(3007853) Bacteria identified in Skin by Aerobe culture
5
25
2.22
0.77
4.6
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
5
25
2.22
0.77
2.4
9.2
mmol/l
101.6
104.0
—
5
25
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
21
176
1.87
0.68
10.6
7.3
u/l
78.4
80.1
0.09
21
165
(3019225) pH of Specimen
0
20
0.00
0.63
0.0
4.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
21
0.00
0.63
0.0
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
16
126
1.66
0.53
3.1
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
5
32
1.69
0.45
1.0
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
22
194
1.72
0.43
26.5
15.9
%
14.1
13.8
0.39
22
187
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
5
35
1.52
0.42
7.2
3.2
ng/l
13.2
53.2
—
5
30
(3023520) Reticulocytes [#/volume] in Blood
0
18
0.00
0.41
0.0
1.4
—
80.3
—
0
10
(3026493) Urate [Moles/volume] in Serum or Plasma
6
40
1.64
0.40
3.7
2.8
umol/l
313.8
7530.1
—
6
31
(3018418) pH of Serum or Plasma
10
74
1.56
0.39
1.9
4.4
—
7.4
—
0
15
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
7
53
1.43
0.34
6.3
4.9
ug/l
2.2
1.7
—
7
43
(1761868) Lipid panel - Serum or Plasma
6
82
0.66
0.29
2.0
3.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
9
75
1.30
0.29
2.7
3.8
mmol/l
2.3
2.4
—
9
68
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
37
1.43
0.25
1.2
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
13
109
1.37
0.25
6.5
3.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
6
47
1.35
0.22
2.0
1.5
nmol/l
21.0
20.1
—
6
35
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
11
0.00
0.22
0.0
3.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
11
0.00
0.22
0.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3013512) EKG study
5
66
0.70
0.20
1.8
4.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
16
142
1.31
0.19
3.8
2.3
u/l
102.4
47.4
0.68
16
133
(3044640) Blood type and Crossmatch panel - Blood
7
83
0.79
0.18
2.6
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
8
72
1.16
0.09
4.1
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
10
96
1.07
0.00
1.7
2.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
13
128
1.03
0.00
5.8
4.9
mmol/l
7.0
6.5
0.29
13
119
(3003694) ABO and Rh group [Type] in Blood
5
53
0.93
0.00
1.0
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
6
61
0.98
0.00
3.8
3.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
5
0.00
0.00
0.0
1.0
—
4.5
—
0
5
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
5
0.00
0.00
0.0
1.2
—
0.8
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
6
60
1.00
0.00
2.8
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
21
211
0.98
0.00
17.5
13.9
ml/min/173m2
82.2
79.5
0.27
14
179
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
2.2
—
4.0
—
0
6
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.3
—
169.0
—
0
6
(3027315) Oxygen [Partial pressure] in Blood
0
5
0.00
0.00
0.0
1.0
—
10.3
—
0
5
(4034850)
0
8
0.00
0.00
0.0
5.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
431.5
—
0
6
(3021901) Oxygen saturation in Capillary blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_SOFTTISSUEINOTH and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_SOFTTISSUEINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_SOFTTISSUEINOTH – Soft tissue disorders in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data